Live Breaking News & Updates on Cancer Research Horizons

Stay updated with breaking news from Cancer research horizons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cancer treatment two and a half times more ef

<ul>
<li><strong>Cancer Research UK-funded scientists at the Cancer Research UK Scotland Institute discover that tumours with high levels of mitochondrial DNA mutations are two and a half times more likely to respond to treatment.&nbsp;</strong></li>
<li><strong>Link between mitochondria &ndash; which generates energy for cancer &ndash; and response to treatment shown for the first time.&nbsp;</strong></li>
<li><strong>Discovery opens up possibility for tests to identify patients with defective mitochondria and treatments which disrupt cancer&rsquo;s energy sources.</strong></li>
</ul>
....

United Kingdom , United States , Iain Foulkes , Payam Gammage , Ed Reznik , Pretzel Therapeutics Inc , Cancer Research United , Method Of Research , Group Leader , Cancer Research United Kingdom Scotland Institute , Cancer Research United Kingdom , Cancer Research Horizons , University Of Glasgow , Memorial Sloan Kettering Cancer Centre , Cancer Research United Kingdom Funded , Nature Cancer , Attending Computational Oncologist , Memorial Sloan Kettering Cancer Center , Cancer Research , Scientific Advisory Board , Pretzel Therapeutics ,

Scientists discover cancer treatment two-and-a-half times more effective when tumors have defective mitochondria

Scientists discover cancer treatment two-and-a-half times more effective when tumors have defective mitochondria
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Payam Gammage , Memorial Sloan Kettering Cancer Center , Cancer Research Horizons , Cancer Research United Kingdom Scotland Institute , Cancer Research United Kingdom , University Of Glasgow , Group Leader , Nature Cancer ,